Search

Your search keyword '"Erwin G. Van Meir"' showing total 251 results

Search Constraints

Start Over You searched for: Author "Erwin G. Van Meir" Remove constraint Author: "Erwin G. Van Meir" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
251 results on '"Erwin G. Van Meir"'

Search Results

1. Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis

2. Ten-eleven translocation protein 1 modulates medulloblastoma progression

3. The transcriptional landscape of Shh medulloblastoma

4. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

5. Design and synthesis of benzopyran-based inhibitors of the hypoxia-inducible factor-1 pathway with improved water solubility

6. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

7. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

8. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

9. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

10. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

11. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

12. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

13. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

14. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

15. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

16. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

17. Data from Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma

18. Data from A Chimeric Signal Peptide–Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell–Specific Apoptosis

19. Data from Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma

20. Supplementary Figure 2 from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

22. Suppl. Table 1 from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase

24. Supplementary Figures 1 - 3 from Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP

25. Supplementary Figure 1. from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

27. Supplementary Table 2. from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

28. Data from Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration

29. Data from Identification of a Novel Small Molecule HIF-1α Translation Inhibitor

32. Supplementary Figure Legend from Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP

34. Supplementary Figures 4 - 8 from Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP

36. Supplementary Table 1 from BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

37. Supplementary Methods from Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP

39. Data from Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase

40. Supplementary Figures 3-5 from Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4

42. Data from Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4

43. Supplementary Figure Legends 1-2 from Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism

44. Data from Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity

45. Data from Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism

46. Supplementary Figure 2 from Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism

47. Supplementary Figures and Tables from Epidermal Growth Factor Receptor and PTEN Modulate Tissue Factor Expression in Glioblastoma through JunD/Activator Protein-1 Transcriptional Activity

48. Supplementary Figure Legends 1-5 from Targeted Cancer Gene Therapy Using a Hypoxia Inducible Factor–Dependent Oncolytic Adenovirus Armed with Interleukin-4

49. Glioma progression is shaped by genetic evolution and microenvironment interactions

50. Abstract 15: Investigating the spectrum of brain tumors associated with Adgrb3 and Tp53 loss in a mouse model of Li-Fraumeni syndrome

Catalog

Books, media, physical & digital resources